Carotid Artery Stenosis, Stroke, TIA
Conditions
Keywords
White Matter Hyperintensity, Stroke, Carotid Artery Plaque Inflammation, FDG PET, MRI, TIA
Brief summary
The investigators hypothesize that inflammation in carotid plaque is predictive of the extent of ischemic lesion burden on the brain and will add to risk stratification for individuals with carotid disease.
Detailed description
Objectives: 1. To investigate the relationship of carotid inflammation, as measured by FDG positron emission tomography (PET) to standardized uptake value in atherosclerotic plaque, with the number of covert brain infarcts. 2. To investigate the relationship of FDG PET standardized uptake value with the relative volume of white matter hyperintensity. 3. To correlate vascular inflammation in the entire aorta and aortoiliac vessels to carotid inflammation and cerebral infarcts and white matter disease.
Interventions
RADIATIONPET/CT imaging with F-18 fluorodeoxyglucose
Dose of 5 MBq/kg F-18-FDG given to fasting participant. Nuclear whole body imaging starting at 3 hours post-injection. The relation of the PET/CT image results and both the number of covert brain infarcts and the extent of white matter MRI hyperintensity will be investigated.
Sponsors
The Ottawa Hospital
Ottawa Heart Institute Research Corporation
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 60 or greater at time of enrollment * Written informed consent from patient or legal representative * Diagnosis of stroke or TIA made by a stroke specialist within 90 days and fulfilling the following criteria: * A TIA must involve a focal speech/language, motor or visual deficit (transient monocular blindness, amaurosis fugax) referable to the distribution of a carotid artery and lasting less than 24 hours. * A stroke consisting of deficits as noted above with duration greater than 24 hours and/or confirmed on cerebral imaging. Post event Modified Rankin Score of 2 or less. * Stroke meets the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria for large artery atherosclerosis * Carotid Doppler, CTA or MRA confirming the presence of bilateral atherosclerotic disease resulting in carotid stenosis of any degree. Stenosis will be measured following the method used in NASCET for CTA and MRA. Carotid Doppler measurements will follow the criteria defined by the Society for Ultrasound consensus conference. * 12 lead ECG or Holter monitor confirming the absence of atrial fibrillation.
Exclusion criteria
* TIA or stroke in the vertebrobasilar system * Index event was primary hemorrhage * History of intermittent atrial fibrillation * Cardiac source of embolus suspected as cause of index event (artificial valve, segmental or global LV dysfunction, congenital cardiac defect) * Diagnosis of vasculitis, dissection, or non-atherosclerotic carotid disease (Ehlers-Danlos, Marfans) * Sinovenous thrombosis, endocarditis or hypercoagulable state * Pacemaker, ICD or other contraindications to MRI * Diminished Kidney Function * Contraindication to radiation exposure (eg: pregnancy) * Severe Claustrophobia
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Plaque Inflammation | 30 days | The extent to which plaque inflammation, as measured by the extent of FDG uptake, contributes to the number of covert infarcts and the magnitude of white matter hyperintensity. |
Countries
Canada
Outcome results
None listed